Henry C. Settle
Nessuna posizione attualmente
Profilo
Mr. Henry C.
Settle, Jr. MBA, is Independent Director at KineMed, Inc. He is on the Board of Directors at KineMed, Inc.
Mr. Settle was previously employed as Chief Financial Officer by Emiliem, Inc., Chief Financial Officer by SuperGen, Inc., Partner-Life Sciences Practice by Ernst & Young LLP, a Principal by Affymetrix, Inc., a Principal by eConvergent, Inc., and a Principal by Theravance, Inc.
He received his undergraduate degree from the University of California, Santa Barbara and an MBA from the University of California, Los Angeles.
Precedenti posizioni note di Henry C. Settle
| Società | Posizione | Fine |
|---|---|---|
| KINEMED INC | Direttore/Membro del Consiglio | - |
| KINEMED INC | Direttore Finanziario/CFO | 01/01/2005 |
| KINEMED INC | Direttore/Membro del Consiglio | - |
eConvergent, Inc.
 eConvergent, Inc. Miscellaneous Commercial ServicesCommercial Services eConvergent, Inc. provides business consulting specializing in marketing. The company was founded by Clyde Foster, Steve Kimball, and Dane C. Foyer on September 7, 1999 and is headquartered in Pleasanton, CA. | Corporate Officer/Principal | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Formazione di Henry C. Settle
| University of California, Los Angeles | Masters Business Admin |
| University of California, Santa Barbara | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
eConvergent, Inc.
eConvergent, Inc. Miscellaneous Commercial ServicesCommercial Services eConvergent, Inc. provides business consulting specializing in marketing. The company was founded by Clyde Foster, Steve Kimball, and Dane C. Foyer on September 7, 1999 and is headquartered in Pleasanton, CA. | Commercial Services |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA. | Commercial Services |
- Borsa valori
- Insiders
- Henry C. Settle